1290 related articles for article (PubMed ID: 19174039)
21. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Legido J; García-Sanz I; Pajares JM
Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
[TBL] [Abstract][Full Text] [Related]
23. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
24. [What role today for Helicobacter pylori in peptic ulcer?].
Cadiot G
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):409-14. PubMed ID: 12700497
[TBL] [Abstract][Full Text] [Related]
25. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers.
Publig W; Wüstinger C; Zandl C
Wien Klin Wochenschr; 1994; 106(9):276-9. PubMed ID: 8023522
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial.
Schilling D; Demel A; Nüsse T; Weidmann E; Riemann JF
Endoscopy; 2003 May; 35(5):393-6. PubMed ID: 12701009
[TBL] [Abstract][Full Text] [Related]
27. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
28. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection.
Ramsoekh D; van Leerdam ME; Rauws EA; Tytgat GN
Clin Gastroenterol Hepatol; 2005 Sep; 3(9):859-64. PubMed ID: 16234022
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori-negative nonsteroidal anti-inflammatory drug-negative ulcer.
McColl KE
Gastroenterol Clin North Am; 2009 Jun; 38(2):353-61. PubMed ID: 19446263
[TBL] [Abstract][Full Text] [Related]
30. Role of Helicobacter pylori infection in peptic ulcer haemorrhage.
Morgando A; Giordanino C; Baronio M; Pellicano R; Rizzetto M
Minerva Med; 2006 Feb; 97(1):47-50. PubMed ID: 16565698
[TBL] [Abstract][Full Text] [Related]
31. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
[TBL] [Abstract][Full Text] [Related]
32. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding.
Gisbert JP; Calvet X; Feu F; Bory F; Cosme A; Almela P; Santolaria S; Aznárez R; Castro M; Fernández N; García-Grávalos R; Cañete N; Benages A; Montoro M; Borda F; Pérez-Aisa A; Piqué JM
Helicobacter; 2007 Aug; 12(4):279-86. PubMed ID: 17669099
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
Russell RI
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
[TBL] [Abstract][Full Text] [Related]
34. [Diagnosis of Helicobacter pylori infections--how, when and in whom?].
Wildner-Christensen M; Schaffalitzky de Muckadell OB
Ugeskr Laeger; 2000 Jun; 162(26):3743-7. PubMed ID: 10925639
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of a delayed test for the diagnosis of Helicobacter pylori infection in bleeding peptic ulcer.
Güell M; Artigau E; Esteve V; Sánchez-Delgado J; Junquera F; Calvet X
Aliment Pharmacol Ther; 2006 Jan; 23(1):53-9. PubMed ID: 16393280
[TBL] [Abstract][Full Text] [Related]
36. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
37. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA
Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
[TBL] [Abstract][Full Text] [Related]
38. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
39. Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users.
Chan FK; Ching JY; Suen BY; Tse YK; Wu JC; Sung JJ
Gastroenterology; 2013 Mar; 144(3):528-35. PubMed ID: 23333655
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding.
Gisbert JP; Calvet X; Cosme A; Almela P; Feu F; Bory F; Santolaria S; Aznárez R; Castro M; Fernández N; García-Grávalos R; Benages A; Cañete N; Montoro M; Borda F; Pérez-Aisa A; Piqué JM;
Am J Gastroenterol; 2012 Aug; 107(8):1197-204. PubMed ID: 22613904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
